This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignee: Richter Gedeon Nyrt.. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2022
Title: Zoltán Béni: Innovator in Pharmaceutical Synthesis
Introduction
Zoltán Béni is a notable inventor based in Maglód, Hungary. He has made significant contributions to the field of pharmaceutical synthesis, holding a total of 4 patents. His work focuses on innovative processes that enhance the production of important pharmaceutical compounds.
Latest Patents
One of Zoltán Béni's latest patents is an "Industrial process for the synthesis of nomegestrol-acetate." This invention pertains to the final step of a synthetic process, where Nomegestrol-acetate is synthesized from a specific precursor in the presence of a Pd/C catalyst and acetic acid in a hot ethanolic solution. Another significant patent is for a "Process for the production of 21-methoxy-11-beta-phenyl-19-nor-pregna-4,9-diene-3,20-dione derivatives." This process involves the synthesis of compounds using specific starting materials and reagents, showcasing his expertise in chemical synthesis.
Career Highlights
Zoltán Béni is currently associated with Richter Gedeon Nyrt., a prominent pharmaceutical company. His role in the company allows him to apply his innovative ideas and contribute to the development of new pharmaceutical products. His work has been instrumental in advancing the synthesis processes within the industry.
Collaborations
Zoltán has collaborated with notable colleagues such as Sándor Mahó and János Csörgei. These collaborations have likely enriched his research and development efforts, leading to successful innovations in pharmaceutical synthesis.
Conclusion
Zoltán Béni's contributions to the field of pharmaceutical synthesis are noteworthy, with several patents that reflect his innovative spirit. His work continues to impact the industry positively, paving the way for advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
